StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.01−0.38 (-0.79%)

Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%

Conmed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Conmed's revenue for the twelve months ending Sep 30, 2026 was $1.37B, up 1.6% year over year. For fiscal 2025 it was $1.37B, up 5.2% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $1.37B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.37B+5.2%
FY2024Dec 31, 2024$1.31B+5.0%
FY2023Dec 31, 2023$1.24B+19.1%
FY2022Dec 31, 2022$1.05B+3.4%
FY2021Dec 31, 2021$1.01B+17.2%
FY2020Dec 31, 2020$862.46M-9.7%
FY2019Dec 31, 2019$955.10M+11.1%
FY2018Dec 31, 2018$859.63M+7.9%
FY2017Dec 31, 2017$796.39M+4.3%
FY2016Dec 31, 2016$763.52M+6.2%
FY2015Dec 31, 2015$719.17M-2.8%
FY2014Dec 31, 2014$740.06M-3.0%
FY2013Dec 31, 2013$762.70M-0.6%
FY2012Dec 31, 2012$767.14M+5.8%
FY2011Dec 31, 2011$725.08M+1.6%
FY2010Dec 31, 2010$713.72M+2.7%
FY2009Dec 31, 2009$694.74M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$335.56M-0.7%
Q2 FY2026Jun 30, 2026$343.49M+0.3%
Q1 FY2026Mar 31, 2026$317.05M-1.3%
Q4 FY2025Dec 31, 2025$373.20M+7.9%
Q3 FY2025Sep 30, 2025$337.93M+6.7%
Q2 FY2025Jun 30, 2025$342.35M+3.1%
Q1 FY2025Mar 31, 2025$321.26M+2.9%
Q4 FY2024Dec 31, 2024$345.94M+5.8%
Q3 FY2024Sep 30, 2024$316.70M+4.0%
Q2 FY2024Jun 30, 2024$332.10M+4.5%
Q1 FY2024Mar 31, 2024$312.27M+5.7%
Q4 FY2023Dec 31, 2023$327.05M+30.4%
Q3 FY2023Sep 30, 2023$304.58M+10.7%
Q2 FY2023Jun 30, 2023$317.65M+14.6%
Q1 FY2023Mar 31, 2023$295.47M+21.9%
Q4 FY2022Dec 31, 2022$250.87M-8.4%
Q3 FY2022Sep 30, 2022$275.09M+10.6%
Q2 FY2022Jun 30, 2022$277.19M+8.6%
Q1 FY2022Mar 31, 2022$242.33M+4.1%
Q4 FY2021Dec 31, 2021$273.97M+8.4%
Q3 FY2021Sep 30, 2021$248.83M+4.6%
Q2 FY2021Jun 30, 2021$255.16M+61.7%
Q1 FY2021Mar 31, 2021$232.68M+8.7%
Q4 FY2020Dec 31, 2020$252.83M-4.5%
Q3 FY2020Sep 30, 2020$237.84M+1.8%
Q2 FY2020Jun 30, 2020$157.79M-33.8%
Q1 FY2020Mar 31, 2020$214.01M-2.0%
Q4 FY2019Dec 31, 2019$264.87M+9.2%
Q3 FY2019Sep 30, 2019$233.59M+15.5%
Q2 FY2019Jun 30, 2019$238.26M+12.0%
Q1 FY2019Mar 31, 2019$218.38M+8.1%
Q4 FY2018Dec 31, 2018$242.44M+8.9%
Q3 FY2018Sep 30, 2018$202.31M+6.4%
Q2 FY2018Jun 30, 2018$212.82M+7.9%
Q1 FY2018Mar 31, 2018$202.06M+8.3%
Q4 FY2017Dec 31, 2017$222.56M+9.0%
Q3 FY2017Sep 30, 2017$190.12M–
Q2 FY2017Jun 30, 2017$197.15M–
Q1 FY2017Mar 31, 2017$186.57M–
Q4 FY2016Dec 31, 2016$204.09M–

More Conmed figures

See a number that looks wrong?